Navigation Links
Shellgel 1.2% Sodium Hyaluronate

ProductsShellgel 1.2% Sodium Hyaluronate
Company Cytosol Ophthalmics
Item Shellgel 1.2% Sodium Hyaluronate
Features SHELLGEL is intended for use during surgery in the anterior and posterior segments of the human eye. Procedures include:
  • Cataract extraction
  • Intraocular lens (IOL) implantation
  • Corneal transplantation surgery
  • Glaucoma filtering surgery
  • Surgical procedures to reattach the retina
Description SHELLGEL is a sterile nonpyrogenic, transparent viscoelastic solution of highly purified sodium hyaluronate. SHELLGEL contains 12 mg/mL of high molecular weight (greater than 1 million daltons) sodium hyaluronate dissolved in physiological saline. In the limit of zero shear rate, the viscosity is 105,000 cps (105 Pa s) at 25C, and the osmolality is approximately 320 milliosmols. Sodium hyaluronate is a naturally occurring polysaccharide composed of sodium glucuronate and N-acetylglucosamine found throughout the tissues of both man and animals. SHELLGEL is prepared from the dermis of rooster combs.

SHELLGEL is a sterile viscoelastic preparation supplied in a disposable glass syringe delivering 0.8 mL of sodium hyaluronate dissolved in physiological saline. Each mL contains 12 mg of sodium hyaluronate, 9 mg of sodium chloride and q.s. sterile water for injection USP. Sodium hydroxide and or hydrochloric acid are used to adjust pH (if necessary). SHELLGEL is sterile filtered and aseptically transferred to syringes. The filled syringes are sealed and the final packaging is sterilized by irradiation. Contents are sterile and nonpyrogenic in unopened and undamaged pouches.

Info Cytosol Ophthalmics
Customer Service: (800) 234-5166
Web site: http://www.cytosol.com/

Related medicine products :

1. SAFE-T-FILL Blood Gas Capillary Tubes Sodium Heparin
2. SAFE-T-FILL Sodium Fluoride
3. BD Vacutainer® Specialty Tubes - Sodium Polyanetholesulfonate (SPS)
4. Sodium
5. Sodium, Fecal
6. Sodium, Fluid
7. Sodium, Plasma or Serum
8. Sodium, Urine
For the quantitative in vitro determination of Aspartate Aminotransferase (AST) in serum and plasma....
Enzymatic Clearance assay for the in vitro quantitative determination of LDL-cholesterol in human serum and plasma....
This is an Immunological assay intended for the quantitative in vitro determination of haemoglobin A1c (HbA1c) in whole blood....
For the quantitative in vitro determination of Sodium in serum and plasma....
Medicine Products:
(Date:2/28/2017)... Los Angeles, CA (PRWEB) , ... February 28, 2017 , ... ... prostate cancer and vasectomies. In studying approximately 800 deaths from prostate cancer, the researchers ... prostate cancer and 20% more likely to get fatal prostate cancer. Although the increased ...
(Date:2/28/2017)... ... February 28, 2017 , ... TruClinic Inc. ... intelligence company based in New York. , “Ensuring an intuitive, user-friendly patient experience ... unaltered. Those two fundamental reasons are the reasons this acquisition is an obvious ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... 2017, from 4:30-5:30 p.m. at the 11th Annual RISE Nashville Summit. RISE Nashville ... compliance, performance analytics, and engagement strategies. , The discussion will include best practices ...
(Date:2/27/2017)... ... February 27, 2017 , ... Hotze Health ... announces Chris Brandl as its New Guest Director. , Brandl is a ... throughout his career. He began his professional career at Omnium Worldwide, now known ...
(Date:2/27/2017)... PORT RICHEY, Fla. (PRWEB) , ... February 27, 2017 , ... ... use disorder, but concern for women who become dependent on opioid painkillers has fallen ... among female patients, compared to a 237% increase in fatal overdoses in male populations.(1) ...
Breaking Medicine News(10 mins):
(Date:2/28/2017)... ... and Markets has announced the addition of the "Active Pharmaceutical ... The global active pharmaceutical ingredients (API) market is ... The rising prevalence of lifestyle-induced & age-related diseases and cancer is ... recombinant molecular technologies and high capitalization for development of novel drugs ...
(Date:2/28/2017)... SINGAPORE and SAN FRANCISCO , February 27, 2017 ... four Se D ... portfolio of biotechnology assets   LOI contemplates capital ... term growth plan for building shareholder value   Amarantus names ... interim-CFO of Amarantus   SeD Biomedical Inc. ...
(Date:2/28/2017)... February 28, 2017 The global  pulse oximeters market  is ... by Grand View Research, Inc. The pulse oximeters market is anticipated to witness ... prevalence of target diseases such as chronic obstructive pulmonary disease (COPD), sleep apnea, ... ... Grand View Research Logo ...
Breaking Medicine Technology: